NYSE · CNC
Centene Corp.
Healthcare · Medical - Healthcare Plans
$61.02▼ 1.77% ($1.10)today
As of 3:56 PM ET
Market cap
$30.14B
P/E
-5.87
EPS (TTM)
-$10.25
Next earnings
Oct 27, 2026
Valuation
P/E valuation
A P/E estimate isn't available here
A usable earnings figure and valuation multiple are needed for a P/E estimate. Review the financial inputs or compare another method.
USD · Trailing earnings · Price used $61.02 · Price Oct 1, 7:56 PM UTC
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 74.16% over the last year. Revenue grew 8.72% over the trailing twelve months. Operating margin moved from 1.08% to -2.82%. Free cash flow grew 730.37% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 3rd percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at -2.82%. Revenue grew 8.72% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Return analysis
Company profile
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.
Market multiples
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 2 shares became 3
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Analyst consensus
27
Buy
16
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 27, 2026
Q3 FY26 · EPS est $0.10 · Revenue est $47.11B
View
Institutional Sentiment
Centene Corp. · CNC
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.